Research on Pei Zhengxue's Formulation Series

3.3 Effects of Pei’s Soft Liver and Anti-Bloating Pill on Immune Organs—Thymus and Spleen—in Tumor-Bearing Mice

Chapter 291

### 3.3 Effects of Pei’s Soft Liver and Anti-Bloating Pill on Immune Organs—Thymus and Spleen—in Tumor-Bearing Mice

From Research on Pei Zhengxue's Formulation Series · Read time 1 min · Updated March 22, 2026

Keywords方药研究, 实验研究, 配方资产, 转化沟通, 2 体会与展望

Section Index

  1. 3.3 Effects of Pei’s Soft Liver and Anti-Bloating Pill on Immune Organs—Thymus and Spleen—in Tumor-Bearing Mice

3.3 Effects of Pei’s Soft Liver and Anti-Bloating Pill on Immune Organs—Thymus and Spleen—in Tumor-Bearing Mice

The thymus and spleen of the model control group mice are both significantly smaller in size and lighter in weight, with some thymuses having unclear lobes and appearing grayish-white, and the spleens turning pale red. The thymus indices (TI) of the PRGXP small-, medium-, and large-dose groups as well as the BM group are all higher than those of the model control group. Among them, the TI of the PRGXP medium-dose group is (53.2±15.6) mg/10 g, an increase of 31.4% compared with the model control group, which is statistically significant (P<0.05). Compared with the blank group, the TI of the model control group mice is significantly lower (P<0.05). The spleen indices (SI) of the PRGXP small-, medium-, and large-dose groups as well as the BM group are (58.9±14.5) mg/10 g, (65.0±10.1) mg/10 g, (55.2±15.9) mg/10 g, and (63.6±15.8) mg/10 g, respectively, all of which are higher than those of the model control group, and compared with the model control group

Research on Pei Zhengxue’s series of prescriptions

are statistically significant (p<0.05); compared with the blank group, the SI of the model control group mice is significantly lower (p<0.05). There is no statistically significant difference among the PRGXP small-, medium-, and large-dose groups as well as the BM group (p>0.05). (See Table 2, Figures 3 and 4)

Table 2: Effects of Pei’s Soft Liver and Anti-Bloating Pill on Thymus and Spleen Indices in Tumor-Bearing Mice (x̄±S)

GroupDosage (g·kg⁻¹)Number of MiceTI (mg/10 g)TI Increase (%)SI (mg/10 g)SI Increase (%)
Blank Group1260.0±11.974.9±24.5
Model Control Group1240.5±6.344.8±12.6
PRGXP Small-Dose Group1.01245.5±6.212.358.9±14.531.5
PRGXP Medium-Dose Group2.01253.2±15.631.465.0±10.145.1
PRGXP Large-Dose Group4.01247.7±23.317.855.2±15.923.2
BM Group0.251252.9±17.330.663.6±15.842.0

Note: Compared with the model control group, p<0.05; compared with the blank group, p<0.05


Figure 3: Effects of Pei’s Soft Liver and Anti-Bloating Pill on Thymus Index in Tumor-Bearing Mice

(Compared with the model control group, *p<0.05; compared with the blank group, p<0.05)


Figure 4: Effects of Pei’s Soft Liver and Anti-Bloating Pill on Spleen Index in Tumor-Bearing Mice (n=12; x̄±s)

(Compared with the model control group*, p<0.05; ▲ compared with the blank group, p<0.05)


This chapter is prepared for online research and reading; for external materials, please align with original publications and the review process.